JB Pharma reports Q2 FY26 unaudited results: revenue up 8% to INR 1,085 crores; EBITDA up 12% to INR 319 crores; net profit up 19% to INR 208 crores, driven by domestic brand growth and a recovering CDMO business.
AI Assistant
J B Chemicals & Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.